AFT Pharmaceutical's multi-billion R&D opportunity
Welcome to HotCopper’s latest Watchlist, where we’ve been joined by AFT Pharmaceuticals (ASX:AFP) founder and chief executive Hartley Atkinson to discuss its expanding global reach and the @tentative” FDA approval the company has just hauled i...
Market Cap $0
!
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Last update - 10.00am 03/08/2026 (20 minute delay)
?
| Day | ||||||||
|---|---|---|---|---|---|---|---|---|
| Open | 0.0¢ | Day High | 0.0¢ | Day Low | 0.0¢ | |||
| Daily Volume | 0 | |||||||
| Bids | Sellers | |||||
|---|---|---|---|---|---|---|
| Number | Price | Volume | Number | Price | Volume | |
| 0 | 0.9¢ | 0 | 0 | 1.0¢ | 0 | |
Directors & Senior Management
| Mr. Andrew Penkethman | Independent Non-Executive Director |
| Mr. Bevan Nigel Hugh Tarratt | Non-Executive Director |
| Mr. Philippe Portella | Executive Technical Director & Non-Independent Director |
| Mr. Richard John Pearce | Independent Non-Executive Chairman |
| Ms. Sarah Hobson | CFO & Joint Company Secretary |
| Ms. Sashi Davies | Independent Non-Executive Director |
| Ms. Siobhan Lancaster | MD, CEO & Non-Independent Director |
| Mr. Steven J. Blower | Independent Non-Executive Director |
| Mr. Steven Wood | Joint Company Secretary |
Data source: ADVFN
